Trial record 1 of 1 for:
LP0145-2240
A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05923099 |
|
Recruitment Status :
Recruiting
First Posted : June 28, 2023
Last Update Posted : May 1, 2024
|
Sponsor:
LEO Pharma
Information provided by (Responsible Party):
LEO Pharma
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 9, 2024 |
| Estimated Study Completion Date : | March 31, 2025 |